Severe infection due to the SARS-CoV-2 coronavirus: Experience of a tertiary hospital with COVID-19 patients during the 2020 pandemic ଝ
A Rodríguez, G Moreno, J Gómez, R Carbonell, E Picó-Plana, C Benavent Bofill, R Sánchez Parrilla, S Trefler, E Esteve Pitarch, L Canadell, X Teixido, L Claverias, M Bodí
Objective: To describe the clinical and respiratory characteristics of a cohort of 43 patients with COVID-19 after an evolutive period of 28 days. Design: A prospective, single-center observational study was carried out. Setting: Intensive care. Patients: Patients admitted due to COVID-19 and respiratory failure. Interventions: None. Variables: Automatic recording was made of demographic variables, severity parameters, laboratory data, assisted ventilation (HFO: high-flow oxygen therapy and IMV: invasive mechanical ventilation), oxygenation (PaO2, PaO2/FiO2) and complications. The patients were divided into three groups: survivors (G1), deceased (G2) and patients remaining under admission (G3). The chi-squared test or Fisher exact test (categorical variables) was used, along with the Mann-Whitney U-test or Wilcoxon test for analyzing the differences between medians. Statistical significance was considered for p < 0.05.
Authorship Study conception and design: AR, MB, LC, GM, RC, and ST. Data acquisition and analysis: AR, MB, JG, GM, RC, EPP, ST, CBB, RSP, LC and XT. Data interpretation: AR, MB, LC, GM, RC, ESP, LC, ESP and EPP. Important intellectual contribution to the contents of the study: AR, MB, GM, RC, ESP, LC, and LC. Drafting of the manuscript: AR, MB, GM, and RC. Critical review of the contents of the article: JG, EPP, CBB, RSP, ST and XT. All the authors approved the final manuscript submitted for evaluation and possible publication.
Conflicts of interest The authors declare that they have no conflicts of interest in relation to the present article. AR has received a research grant from Gilead Science for the study of nebulized antibiotics, and has received fees for teaching conferences from Biomerieux, Astellas, Pfizer, Thermo Fisher, MSD, Gilead, Shionogi and BRHAMS. There are no conflicts of interest in relation to the present study, however. The rest of the authors have no conflicts of interest.
Appendix A. List of research members of the HJ23-COVID-19 Working Group
Clinical laboratory Natalia Bastón-Paz, Carolina Sarvisé-Buil, Frederic Gómez-Bertomeu, Gemma Recio-Comi, Carla Martin-Grau, Silvia Montolio-Breva, Victoria Rivera-Moreno, Modest Sabaté-Piñol, Carmen Molina-Clavero, Nuria Serrat-Orús, Maria Teresa Sans-Mateu and Cristina Gutiérrez-Fornes. Epidemiology and prevention of nosocomial infections M. Montserrat Olona-Cabases.
ICU Nursing Department Xavier Teixidó,..
References
Arentz, Yim, Klaff, Lokhandwala, Riedo et al., Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State, JAMA,
doi:10.1001/jama.2020.6775Barrasa, Rello, Tejada, Martín, Balziskueta et al., SARS-Cov-2 in Spanish Intensive Care: early experience with 15-day survival in Vitoria, Anaesth Crit Care Pain Med,
doi:10.1016/j.accpm.2020.04.001Bellomo, Ronco, Kellum, Mehta, Palevsky, the ADQI workgroup Acute renal failure ---definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group, Crit Care,
doi:10.1186/cc2872Díaz, Rodríguez, Martin-Loeches, Lorente, Mar Martín et al., Impact of obesity in patients infected with 2009 influenza A(H1N1), Chest
Grasselli, Zangrillo, Zanella, Antonelli, Cabrini et al., Baseline Characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, JAMA,
doi:10.1016/j.medin.2020.03.006Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet,
doi:10.1001/jama.2020.5394Kalil, Metersky, Klompas, Muscedere, Sweeney et al., Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society, Clin Infect Dis
Martin-Loeches, Schultz, Vincent, Alvarez-Lerma, Bos et al., Increased incidence of co-infection in critically ill patients with influenza, Intensive Care Med
Moreno, Rodríguez, Reyes, Gomez, Sole-Violan et al., Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study, Intensive Care Med,
doi:10.1186/cc2872Ranieri, Rubenfeld, Thompson, Ferguson, Acute respiratory distress syndrome: the Berlin Definition. ARDS Definition Task Force, JAMA
Richardson, Hirsch, Narasimhan, Crawford, Mcginn et al., Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area, JAMA,
doi:10.1001/jama.2020.6775Rubio, Cabre, Saralegui-Reta, Martin, Zapata, Recomendaciones éticas para la toma de decisiones difíciles en las unidades de cuidados intensivos ante la situación excepcional de crisis por la pandemia por COVID-19: revisión rápida y consenso de expertos, Med Intensiva,
doi:10.1016/j.medin.2020.04.006Sedes, Sanz, Saera, Rodríguez-Rey, Ortega et al., Plan de contingencia para los servicios de medicina intensiva frente a lapandemia COVID-19, Medicina Intensiva,
doi:10.1016/j.medin.2020.04.002Wu, Chen, Cai, Xia, Zhou et al., Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern Med,
doi:10.1016/S2213-2600(20)30079-5Yang, Yu, Xu, Shu, Xia et al., Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med,
doi:10.1056/NEJMoa2002032
